BIOMAT Database Logo BIOMAT Database Logo

Urinary fibrin-fibrinogen degradation products and acute renal-transplant rejection. 1973

N Lameire, and G Baele, and J Hilderson, and S Ringoir

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006385 Hemagglutination Inhibition Tests Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. Hemagglutination Inhibition Test,Inhibition Test, Hemagglutination,Inhibition Tests, Hemagglutination,Test, Hemagglutination Inhibition,Tests, Hemagglutination Inhibition
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal

Related Publications

N Lameire, and G Baele, and J Hilderson, and S Ringoir
[Urinary and serum fibrin/fibrinogen degradation products in renal transplant rejection (author's transl)].
June 1977, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
N Lameire, and G Baele, and J Hilderson, and S Ringoir
[Qualitative analysis of urinary fibrin/fibrinogen degradation products in renal transplant rejection (author's transl)].
November 1978, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
N Lameire, and G Baele, and J Hilderson, and S Ringoir
Urinary fibrin-fibrinogen degradation products and intraglomerular fibrin-fibrinogen deposition in various renal diseases.
February 1981, Thrombosis research,
N Lameire, and G Baele, and J Hilderson, and S Ringoir
Serum and urinary fibrin-fibrinogen degradation products in renal disease.
January 1971, Scandinavian journal of haematology. Supplementum,
N Lameire, and G Baele, and J Hilderson, and S Ringoir
Fragments of urinary fibrin/fibrinogen degradation products and cross-linked fibrin degradation products in various renal diseases.
February 1989, Thrombosis research,
N Lameire, and G Baele, and J Hilderson, and S Ringoir
[Clinical significance of urinary fibrin/fibrinogen degradation products in renal disease. First report: Urinary fibrin/fibrinogen degradation products in primary glomerulonephritis (author's transl)].
January 1978, Nihon Jinzo Gakkai shi,
N Lameire, and G Baele, and J Hilderson, and S Ringoir
[Clinical significance of urinary fibrin/fibrinogen degradation products in renal disease. Second report: Urinary fibrin/fibrinogen degradation products in nephrotic syndrome. (author' transl)].
April 1978, Nihon Jinzo Gakkai shi,
N Lameire, and G Baele, and J Hilderson, and S Ringoir
Urine fibrin degradation products in detection and management of acute and chronic renal transplant rejection.
June 1977, Clinical nephrology,
N Lameire, and G Baele, and J Hilderson, and S Ringoir
Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
June 1986, The Journal of laboratory and clinical medicine,
N Lameire, and G Baele, and J Hilderson, and S Ringoir
Urinary fibrin-fibrinogen degradation products (FDP) and glomerulonephritis.
January 1974, Acta medica Scandinavica,
Copied contents to your clipboard!